CircRNA Synthesis Market Size & Share, By Product & Service (Reagents & Kits), Application (Therapeutics Development), End-use - Growth Trends, Regional Insights (U.S., Japan, South Korea, UK, Germany), Competitive Positioning, Global Forecast Report 2025-2034

Market Outlook:

CircRNA Synthesis Market size is projected to grow from USD 183.51 million in 2024 to USD 782.06 million by 2034, with a CAGR surpassing 15.6% throughout the forecast period (2025-2034). The industry revenue for 2025 is anticipated to be USD 209.74 million.

• Base Year Value (2024): USD 183.51 million
• CAGR (2025-2034): 15.6%
• Forecast Year Value (2034): USD 782.06 million
• Historical Data Period: 2021-2034
• Largest Region: Asia Pacific
• Forecast Period: 2025-2034

Market Dynamics:

Growth Drivers & Opportunities

The CircRNA Synthesis Market is experiencing significant growth, primarily driven by advancements in genomic and molecular biology technologies. The increasing recognition of circular RNAs as vital components of gene regulation and their potential as biomarkers for various diseases, including cancers and neurological disorders, play a crucial role in expanding research and development in this sector. Moreover, the rising investment in biotechnology and pharmaceutical companies focused on RNA research is enhancing the landscape for circRNA synthesis, fostering innovation and leading to the development of novel therapeutic applications.

Another significant factor contributing to market growth is the escalating demand for personalized medicine. CircRNAs hold promise in tailoring specific treatments based on individual genetic profiles, thereby facilitating the evolution of precision medicine. This shift is supported by ongoing studies that suggest circRNAs can serve as effective indicators for the diagnosis and prognosis of diseases, creating opportunities for companies involved in the synthesis and application of circRNA.

Furthermore, collaborations between academic institutions and industry players are driving research initiatives and fostering new discoveries in circRNA biology. These partnerships are not only enhancing the understanding of circRNA functions but also accelerating the translation of research findings into commercial products. Additionally, the advent of innovative synthesis methods and platforms enhances the efficiency and scalability of circRNA production, making it more accessible for researchers and clinicians.

Report Scope

Report Coverage	Details
Segments Covered	Product & Services, Application, End Use
Regions Covered	• North America (United States, Canada, Mexico) • Europe (Germany, United Kingdom, France, Italy, Spain, Rest of Europe) • Asia Pacific (China, Japan, South Korea, Singapore, India, Australia, Rest of APAC) • Latin America (Argentina, Brazil, Rest of South America) • Middle East & Africa (GCC, South Africa, Rest of MEA)
Company Profiled	LGC Biosearch Technologies, Creative Biogene,SBS Genetech, Applied Biological Materials, GenScript, Amerigo Scientific, BOC Sciences,GeneCopoeia,, Guangzhou Geneseed Biotech., Creative Biolabs

Industry Restraints:

Despite the promising landscape, the CircRNA Synthesis Market faces several significant restraints that could hinder its growth. One of the notable challenges is the lack of standardized methodologies for circRNA synthesis and analysis, which can lead to inconsistencies in research outcomes. This inconsistency creates challenges in validating results and complicating the regulatory approval processes for circRNA-based therapies.

Moreover, the high costs associated with the synthesis of circRNAs and the required research can act as a barrier for smaller laboratories and research institutions. Limited financial resources may restrict their ability to engage in extensive circRNA studies, ultimately slowing down the progress of innovative discoveries in this field. Additionally, the complexity of circRNA biogenesis and function poses challenges for researchers, as the intricate interactions and pathways involved in circRNA biology are still being elucidated.

Intellectual property issues also represent a significant concern in the circRNA field. With a rapidly evolving scientific landscape, securing patents around circRNA technologies can become contentious and may deter new entrants from innovating freely. These

Report Scope

Report Coverage	Details
Segments Covered	Product & Services, Application, End Use
Regions Covered	• North America (United States, Canada, Mexico) • Europe (Germany, United Kingdom, France, Italy, Spain, Rest of Europe) • Asia Pacific (China, Japan, South Korea, Singapore, India, Australia, Rest of APAC) • Latin America (Argentina, Brazil, Rest of South America) • Middle East & Africa (GCC, South Africa, Rest of MEA)
Company Profiled	LGC Biosearch Technologies, Creative Biogene,SBS Genetech, Applied Biological Materials, GenScript, Amerigo Scientific, BOC Sciences,GeneCopoeia,, Guangzhou Geneseed Biotech., Creative Biolabs

Industry Restraints: can create uncertainty and affect the overall growth trajectory of the CircRNA Synthesis Market, highlighting the need for addressing these challenges to facilitate further advancements.

Regional Forecast:

North America

The CircRNA synthesis market in North America, particularly in the United States and Canada, is likely to experience robust growth due to a synergistic environment fostered by strong research institutions and biotechnology firms. The U.S. stands out with its substantial investment in genomics and diagnostics, driven by the presence of leading pharmaceutical companies. This investment in R&D is coupled with advanced healthcare infrastructure that facilitates the adoption of innovative therapies, including those relying on circRNA technologies. Canada, with its emerging biotechnology landscape, is also carving a niche, driven by collaborations between academic institutions and industry that aim to develop novel RNA-based therapeutics.

Asia Pacific

The Asia Pacific region, notably Japan, South Korea, and China, is poised for substantial growth in the CircRNA synthesis market. China's rapid advancements in biotechnology, considerable government funding, and a strong focus on genomics research catalyze its ascent as a significant player in the market. Japan and South Korea follow closely, where advanced research capabilities and a mature pharmaceutical sector support the exploration and development of circular RNA applications. These countries are also witnessing a rising interest in personalized medicine and innovative gene therapies, which are propelling the demand for advanced synthesis techniques and materials related to circRNA.

Europe

In Europe, countries such as the UK, Germany, and France are expected to lead the CircRNA synthesis market as they exhibit a blend of cutting-edge research and a well-established pharmaceutical ecosystem. The UK is notable for its strong foundations in biotech and life sciences, providing a conducive environment for circRNA research and development. Germany, with its advanced manufacturing capabilities and emphasis on biomedical research, is crucial for driving innovation in the synthesis of circrna. France is also witnessing significant developments, especially in academic and clinical settings, where research on the therapeutic potential of circRNA is increasingly prevalent. The collaborative nature of research and development across these nations is key to advancing the market further.

Segmentation Analysis:

In terms of segmentation, the global CircRNA Synthesis market is analyzed on the basis of Product & Services, Application, End Use.

Product & Services Segment

The CircRNA synthesis market is primarily driven by a variety of products and services designed to facilitate the synthesis of circular RNAs. Key products include synthetic CircRNA, which is increasingly utilized in research and therapeutic applications due to its stability and role in gene regulation. The market also features specialized reagents and kits that aid in the construction and analysis of CircRNA, appealing to both academic and commercial laboratories. Services offered by various companies, such as custom CircRNA synthesis and sequencing services, enable clients to access tailored solutions for their specific research needs. Among these offerings, custom synthesis services exhibit the fastest growth, driven by increasing demand for personalized applications.

Application Segment

In terms of application, the CircRNA synthesis market is segmented into research, therapeutic development, and diagnostics. Research applications dominate the market, as academic institutions and biotech companies invest heavily in understanding the functional roles of CircRNA in various biological processes. This segment is expected to witness substantial growth, propelled by continuous advancements in RNA biology and the expanding body of CircRNA-related studies. Therapeutic applications, particularly in cancer and genetic disorders, are also gaining traction as CircRNA's potential for drug delivery and gene regulation becomes more recognized. Diagnostics, although currently smaller in size, are emerging as a critical area for CircRNA application, particularly in biomarker development and disease detection, showcasing potential for rapid growth.

End Use Segment

The end-use segment of the CircRNA synthesis market encompasses academic research institutions, pharmaceutical and biotechnology companies, and diagnostic laboratories. Academic institutions are currently the largest end-users, benefiting from funding opportunities and their focus on innovative research. However, pharmaceutical and biotechnology companies represent the fastest-growing end-user segment, driven by their need for advanced molecular tools to support drug discovery and development processes. The involvement of these companies underscores the translational potential of CircRNA research into tangible therapeutic solutions. Diagnostic laboratories are also increasingly integrating CircRNA analysis into their workflows, signaling a future shift towards more personalized healthcare applications.

Competitive Landscape:

The competitive landscape in the CircRNA Synthesis Market is characterized by a range of companies leveraging advanced biotechnological approaches to gain a competitive edge. As the demand for circular RNA (circRNA) research continues to grow, companies are focusing on enhancing their synthesis capabilities, improving product quality, and expanding their service offerings. Key players in this market are investing in research and development to innovate new synthesis methods and applications, which include diagnostics, therapeutics, and functional studies. Collaborations and partnerships are also prominent as firms seek to enhance their technological capabilities and market reach. This dynamic environment is marked by continuous advancements and increasing investments aimed at fostering growth and addressing the diverse needs of the biopharmaceutical industry.

Top Market Players

1. Thermo Fisher Scientific

2. New England Biolabs

3. Takara Bio

4. Bio-Rad Laboratories

5. GeneCopoeia

6. System Biosciences

7. Twist Bioscience

8. QIAGEN

9. Bioneer Corporation

10. Integrated DNA Technologies